6.49 PHARMACOKINETICS OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND IN HEALTHY ADULTS AT STEADY STATE

Declan Martin Quinn; Twyla D. Bode; Graeme Donnelly; Joseph L. Reiz

doi:10.1016/j.jaac.2016.09.368

6.49 PHARMACOKINETICS OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND IN HEALTHY ADULTS AT STEADY STATE

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.368 ◽

2016 ◽

Vol 55 (10) ◽

pp. S219-S220 ◽

Cited By ~ 1

Author(s):

Declan Martin Quinn ◽

Twyla D. Bode ◽

Graeme Donnelly ◽

Joseph L. Reiz

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Steady State ◽

Attention Deficit ◽

Extended Release ◽

Healthy Adults ◽

Release Formulation ◽

Extended Release Formulation ◽

Hyperactivity Disorder

Download Full-text

4.23 PIVOTAL PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF HLD200, A NOVEL DELAYED-RELEASE AND EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE, IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.218 ◽

2016 ◽

Vol 55 (10) ◽

pp. S170

Author(s):

Valerie K. Arnold ◽

Norberto J. DeSousa ◽

Bev Incledon ◽

Floyd R. Sallee ◽

Timothy E. Wilens ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Phase 3 ◽

Pivotal Phase ◽

Release Formulation ◽

Extended Release Formulation ◽

Hyperactivity Disorder ◽

Delayed Release

Download Full-text

Pharmacokinetics of a Guanfacine Extended-Release Formulation in Children and Adolescents with Attention-Deficit–Hyperactivity Disorder

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/s0084-3970(08)79219-3 ◽

2009 ◽

Vol 2009 ◽

pp. 53-54

Author(s):

A. Mack

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Release Formulation ◽

Extended Release Formulation ◽

Hyperactivity Disorder

Download Full-text

6.42 A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY MEASURING THE EFFICACY AND SAFETY OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.362 ◽

2016 ◽

Vol 55 (10) ◽

pp. S217-S218 ◽

Cited By ~ 1

Author(s):

Scott H. Kollins ◽

Andrew J. Cutler ◽

Sohail Khattak ◽

Margaret D. Weiss ◽

Graeme Donnelly ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Multicenter Study ◽

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Double Blind ◽

Release Formulation ◽

Double Blind Placebo ◽

Extended Release Formulation ◽

Hyperactivity Disorder

Download Full-text

Pharmacokinetics of a Guanfacine Extended-Release Formulation in Children and Adolescents with Attention-Deficit–Hyperactivity Disorder

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1592/phco.27.9.1253 ◽

2007 ◽

Vol 27 (9) ◽

pp. 1253-1262 ◽

Cited By ~ 34

Author(s):

Samuel W Boellner ◽

Michael Pennick ◽

Kimberly Fiske ◽

Andrew Lyne ◽

Amir Shojaei

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Release Formulation ◽

Extended Release Formulation ◽

Hyperactivity Disorder

Download Full-text

Single-Dose Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2017.0044 ◽

2018 ◽

Vol 28 (1) ◽

pp. 10-18 ◽

Cited By ~ 10

Author(s):

Ann Childress ◽

Shailly Mehrotra ◽

Jogarao Gobburu ◽

Angus McLean ◽

Norberto J. DeSousa ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Single Dose ◽

Attention Deficit ◽

Extended Release ◽

Healthy Adults ◽

Hyperactivity Disorder ◽

Delayed Release

Download Full-text

Effectiveness of an extended release stimulant medication in treating preschool children with attention deficit hyperactivity disorder (The APS Study)

PsycEXTRA Dataset ◽

10.1037/e657832010-001 ◽

2010 ◽

Author(s):

John H. Fanton

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Preschool Children ◽

Attention Deficit ◽

Extended Release ◽

Stimulant Medication ◽

Hyperactivity Disorder

Download Full-text

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior stimulant treatment

10.26226/morressier.5785edd1d462b80296c9a2a5 ◽

2016 ◽

Author(s):

Jiri Prochazka

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Stimulant Treatment ◽

Hyperactivity Disorder

Download Full-text

A Comparison of the Pharmacokinetics of Methylphenidate Extended-Release Orally Disintegrating Tablets With a Reference Extended-Release Formulation of Methylphenidate in Healthy Adults

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.362 ◽

2017 ◽

Vol 7 (2) ◽

pp. 151-159 ◽

Cited By ~ 1

Author(s):

Ann Childress ◽

Jeffrey G. Stark ◽

Russ McMahen ◽

Dorothy Engelking ◽

Carolyn Sikes

Keyword(s):

Extended Release ◽

Healthy Adults ◽

Release Formulation ◽

Extended Release Formulation ◽

Orally Disintegrating Tablets

Download Full-text

Evaluating the Likelihood to be Helped or Harmed after Treatment with Viloxazine Extended‐Release in Children and Adolescents with Attention Deficit/Hyperactivity Disorder

International Journal of Clinical Practice ◽

10.1111/ijcp.14330 ◽

2021 ◽

Author(s):

Azmi Nasser ◽

Alisa R. Kosheleff ◽

Joseph T. Hull ◽

Tesfaye Liranso ◽

Peibing Qin ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Hyperactivity Disorder

Download Full-text

A Cost-Effectiveness Analysis of Guanfacine Extended-Release Treatment in Pediatric Attention-Deficit/Hyperactivity Disorder

Value in Health ◽

10.1016/j.jval.2016.08.529 ◽

2016 ◽

Vol 19 (7) ◽

pp. A841

Author(s):

S Maeda ◽

K Shimozuma ◽

Y Takeda

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Cost Effectiveness ◽

Attention Deficit ◽

Extended Release ◽

Cost Effectiveness Analysis ◽

Hyperactivity Disorder ◽

Effectiveness Analysis

Download Full-text